Glenmark Pharmaceuticals Limited
Balance Sheet
Last updated:
The balance sheet is a financial statement presenting the value of assets, liabilities and equity of a company. How has Glenmark Pharmaceuticals Limited's balance sheet done over the years? Its assets were worth $143,586,240,000 last year, which is less than in the previous period. 45% of Glenmark Pharmaceuticals Limited’s total assets is currently financed by debt. Its liabilities reached the amount of $65,110,770,000, which means an decrease by -15% compared compared to last year.
Debt to Assets
| 2011 | 50977770000 | 30.33B | 59.51% |
|---|---|---|---|
| 2012 | 58834270000 | 34.56B | 58.75% |
| 2015 | 96875060000 | 66.87B | 69.03% |
| 2016 | 111026360000 | 68.32B | 61.54% |
| 2018 | 130209550000 | 74.32B | 57.08% |
| 2019 | 136788380000 | 76.83B | 56.17% |
| 2020 | 146848070000 | 86.14B | 58.66% |
| 2021 | 156035770000 | 85.39B | 54.73% |
| 2022 | 170832880000 | 76.45B | 44.75% |
| 2024 | 143586240000 | 65.11B | 45.35% |
GLENMARK.NS Balance Sheet (2011 – 2023)
| 2023 | 2021 | 2020 | 2019 | 2018 | 2017 | 2015 | 2014 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|
Assets | ||||||||||
Current assets: | ||||||||||
Cash and cash equivalents | 16.58B | 14.10B | 11.38B | 11.10B | 9.36B | 12.33B | 8.57B | 7.63B | 3.20B | 1.94B |
Short term investments | 57.81M | 328.75M | 763.99M | 696.56M | 1.96B | 1.79B | 146.86M | 107.68M | 0 | 0 |
Net receivables | 18.58B | 31.01B | 25.72B | 24.08B | 30.77B | 23.31B | 24.92B | 25.11B | 0 | 0 |
Inventory | 25.13B | 24.99B | 22.76B | 21.35B | 22.52B | 20.30B | 15.67B | 12.69B | 7.87B | 8.07B |
Other current assets | 13.92B | 2.77B | 12.27B | 11.40B | 33.11B | 13.92B | 9.88B | 7.67B | 18.39B | 15.96B |
Total current assets | 74.28B | 82.82B | 73.59B | 68.03B | 66.96B | 69.88B | 59.09B | 53.23B | 29.47B | 25.98B |
Non-current assets: | ||||||||||
Property, Plant and Equipment | 35.37B | 46.53B | 42.03B | 40.92B | 36.39B | 32.08B | 24.62B | 20.56B | 12.99B | 11.79B |
Goodwill | 673.59M | 600.19M | 580.11M | 528.99M | 547.35M | 521.04M | 574.8M | 579.7M | 608.64M | 605.7M |
Intangible assets | 12.67B | 22.25B | 22.76B | 21.29B | 18.93B | 14.58B | 14.45B | 12.13B | 11.25B | 9.72B |
Long term investments | 7.95B | 556.64M | 518.95M | 507.33M | 448.72M | -1.64B | 202.89M | 257.29M | 0 | 0 |
Other non-current assets | 2.12B | 1.20B | 1.18B | 997.55M | 585.74M | 2.58B | 337.49M | 370.31M | 332.31M | 309.22M |
Total non-current assets | 69.30B | 88.00B | 82.43B | 78.81B | 69.82B | 60.32B | 51.93B | 43.64B | 29.36B | 24.99B |
Total assets | 143.58B | 170.83B | 156.03B | 146.84B | 136.78B | 130.20B | 111.02B | 96.87B | 58.83B | 50.97B |
Liabilities | ||||||||||
| Current liabilities: | ||||||||||
Accounts payable | ||||||||||
Deferred revenue | 0 | 11.98B | 10.61B | 10.49B | 9.09B | 9.05B | 4.34B | 3.63B | 0 | 0 |
Short term debt | 10.79B | 11.90B | 8.72B | 9.11B | 8.74B | -4.36B | 14.81B | 10.91B | 9.32B | 14.91B |
Total current liabilities | 58.18B | 46.89B | 42.01B | 41.25B | 40.21B | 32.87B | 40.01B | 37.11B | 19.01B | 22.51B |
| Non-current liabilities: | ||||||||||
Long term debt | 1.51B | 27.71B | 41.12B | 42.74B | 35.73B | 41.41B | 24.87B | 25.74B | 13.12B | 6.20B |
Deferred tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.47B |
Other non-current liabilities | 5.40B | 311.87M | 600.75M | 632.84M | -62.26M | 26M | -1.89B | 47.44M | 925.59M | 141.02M |
Total non-current liabilities | 6.92B | 29.55B | 43.38B | 44.88B | 36.62B | 41.44B | 28.30B | 29.76B | 15.55B | 7.81B |
Total liabilities | 65.11B | 76.45B | 85.39B | 86.14B | 76.83B | 74.32B | 68.32B | 66.87B | 34.56B | 30.33B |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |